ANIK (STOCKS)
Anika Therapeutics Inc
$9.995000
-0.255000 (-2.49%)
Prev close: $10.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stephen D. Griffin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $144.14M
- Employees
- 288
- P/E (TTM)
- -4.50
- P/B (TTM)
- 1.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.16 | $-0.28 | +0.1154 | +41.90% |
|
Jun 2025 (Q2)
|
$-0.28 | $-0.26 | -0.0216 | -8.36% |
|
Mar 2025 (Q1)
|
$-0.34 | $-0.15 | -0.1938 | -132.56% |
|
Dec 2024 (Q4)
|
$-1.50 | $-0.30 | -1.1991 | -398.50% |
Financial Statements
| Revenues | $112.81M |
| Benefits Costs and Expenses | $122.84M |
| Cost Of Revenue | $51.05M |
| Costs And Expenses | $74.16M |
| Gross Profit | $61.75M |
| Operating Expenses | $74.16M |
| Selling, General, and Administrative Expenses | $48.33M |
| Depreciation and Amortization | $5.61M |
| Research and Development | $25.83M |
| Operating Income/Loss | -$12.40M |
| Income/Loss From Continuing Operations After Tax | -$14.27M |
| Income/Loss From Continuing Operations Before Tax | -$10.03M |
| Income/Loss From Discontinued Operations Net Of Tax | -$18.77M |
| Income Tax Expense/Benefit | $4.23M |
| Income Tax Expense/Benefit, Deferred | $252.00K |
| Net Income/Loss | -$33.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.00K |
| Net Income/Loss Attributable To Parent | -$33.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.27 |
| Diluted Earnings Per Share | -$2.27 |
| Basic Average Shares | 43,032,000 |
| Diluted Average Shares | 43,185,000 |
| Assets | $189.44M |
| Current Assets | $101.59M |
| Inventory | $16.28M |
| Other Current Assets | $85.31M |
| Noncurrent Assets | $87.85M |
| Fixed Assets | $40.68M |
| Intangible Assets | $1.65M |
| Other Non-current Assets | $45.51M |
| Liabilities | $42.63M |
| Current Liabilities | $19.09M |
| Accounts Payable | $4.73M |
| Wages | $8.11M |
| Other Current Liabilities | $6.25M |
| Noncurrent Liabilities | $23.54M |
| Equity | $146.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $146.81M |
| Liabilities And Equity | $189.44M |
| Net Cash Flow From Operating Activities | $8.13M |
| Net Cash Flow From Operating Activities, Continuing | $8.13M |
| Net Cash Flow From Investing Activities | -$1.91M |
| Net Cash Flow From Investing Activities, Continuing | -$1.91M |
| Net Cash Flow From Financing Activities | -$10.63M |
| Net Cash Flow From Financing Activities, Continuing | -$10.63M |
| Net Cash Flow | -$4.40M |
| Net Cash Flow, Continuing | -$4.40M |
| Comprehensive Income/Loss | -$32.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$32.28M |
| Other Comprehensive Income/Loss | $35.28M |